These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2606582)

  • 21. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
    Glasová M; Koníková E; Stasáková J; Babusíková O
    Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of three methods for the determination of the growth fraction in non-Hodgkin's lymphoma.
    Schrape S; Jones DB; Wright DH
    Br J Cancer; 1987 Mar; 55(3):283-6. PubMed ID: 3567062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-Hodgkin's lymphomas: immunologic prognostic studies.
    Hadzi-Pecova L; Petrusevska G; Stojanovic A
    Prilozi; 2007 Jul; 28(1):39-55. PubMed ID: 17921917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric analysis of low grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis.
    Lackowska B; Wasilewska A; Gruchała A; Ryś J; Szklarski W; Niezabitowski A
    Pol J Pathol; 1994; 45(4):263-9. PubMed ID: 7697327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDK1 and cyclin A expression is linked to cell proliferation and associated with prognosis in non-Hodgkin's lymphomas.
    Wolowiec D; Berger F; Ffrench P; Bryon PA; Ffrench M
    Leuk Lymphoma; 1999 Sep; 35(1-2):147-57. PubMed ID: 10512172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transferrin receptor expression by non-Hodgkin's lymphomas. Correlation with morphologic grade and survival.
    Medeiros LJ; Picker LJ; Horning SJ; Warnke RA
    Cancer; 1988 May; 61(9):1844-51. PubMed ID: 3355978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Tac antigen in B cell lymphomas.
    Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
    Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous (H)-thymidine uptake in histological subgroups of human B-cell lymphomas.
    Kvaløy S; Godal T; Marton PF; Steen H; Brenhovd IO; Abrahamsen AF
    Scand J Haematol; 1981 Mar; 26(3):221-34. PubMed ID: 7015478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of neoplastic and reactive cell proliferation in non-Hodgkin's lymphomas linked to patient survival.
    Ffrench M; Magaud JP; Ffrench P; Berger F; Devaux Y; Duhaut P; Shen N; Coiffier B; Bryon PA
    Am J Clin Pathol; 1994 Apr; 101(4):413-20. PubMed ID: 8160629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of proliferation-associated antigens in cutaneous lymphoid infiltrates].
    Baba N
    Nihon Hifuka Gakkai Zasshi; 1990 Apr; 100(5):567-73. PubMed ID: 2395218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma.
    Poggi A; Miniscalco B; Morello E; Comazzi S; Gelain ME; Aresu L; Riondato F
    Vet Comp Oncol; 2015 Dec; 13(4):475-80. PubMed ID: 24341365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
    Cowan RA; Harris M; Jones M; Crowther D
    Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification.
    Christensson B; Tribukait B; Linder IL; Ullman B; Biberfeld P
    Cancer; 1986 Sep; 58(6):1295-304. PubMed ID: 3742454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
    Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
    J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human malignant lymphomas in vitro. Characterization of biopsy cells and establishment of permanent cell lines.
    Sundström C; Nilsson K
    Acta Pathol Microbiol Scand A; 1978 Mar; 86(2):173-84. PubMed ID: 211794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferation kinetics of malignant non-Hodgkin's lymphomas related to histopathology of lymph node biopsies.
    Lang W; Kienzle S; Diehl V
    Virchows Arch A Pathol Anat Histol; 1980; 389(3):397-407. PubMed ID: 7456330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.
    Macartney JC; Camplejohn RS; Alder J; Stone MG; Powell G
    J Clin Pathol; 1986 May; 39(5):542-6. PubMed ID: 3722408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency.
    McDunn SH; Winter JN; Variakojis D; Rademaker AW; Von Roenn JH; Tallman MS; Gordon LI; Bauer KD
    J Clin Oncol; 1991 Aug; 9(8):1334-40. PubMed ID: 1677032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.